Cannabinoid receptor activation reduces TNFα-Induced surface localization of AMPAR-type glutamate receptors and excitotoxicity

[1]  Adam R Ferguson,et al.  Cell Death after Spinal Cord Injury Is Exacerbated by Rapid TNFα-Induced Trafficking of GluR2-Lacking AMPARs to the Plasma Membrane , 2008, The Journal of Neuroscience.

[2]  E. Aizenman,et al.  Assessment of Cell Viability in Primary Neuronal Cultures , 2008, Current protocols in neuroscience.

[3]  E. Beattie,et al.  Rapid Tumor Necrosis Factor α-Induced Exocytosis of Glutamate Receptor 2-Lacking AMPA Receptors to Extrasynaptic Plasma Membrane Potentiates Excitotoxicity , 2008, The Journal of Neuroscience.

[4]  A. Brandon,et al.  Longitudinal comparison of two severities of unilateral cervical spinal cord injury using magnetic resonance imaging in rats. , 2008 .

[5]  R. Carroll,et al.  Characterization of the Role of Microtubule-Associated Protein 1B in Metabotropic Glutamate Receptor-Mediated Endocytosis of AMPA Receptors in Hippocampus , 2007, The Journal of Neuroscience.

[6]  K. Thorn,et al.  Real-Time Imaging of Discrete Exocytic Events Mediating Surface Delivery of AMPA Receptors , 2007, The Journal of Neuroscience.

[7]  K. Mackie.  From Active Ingredients to the Discovery of the Targets: The Cannabinoid Receptors , 2007, Chemistry & biodiversity.

[8]  Neil A. McDonald,et al.  An Essential Role for Constitutive Endocytosis, but Not Activity, in the Axonal Targeting of the CB1 Cannabinoid Receptor , 2007, Molecular Pharmacology.

[9]  J. Rossier,et al.  Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons. , 2007, Journal of neurophysiology.

[10]  S. McAllister,et al.  Biarylpyrazole inverse agonists at the cannabinoid CB1 receptor: importance of the C-3 carboxamide oxygen/lysine3.28(192) interaction. , 2006, Journal of medicinal chemistry.

[11]  M. Wolf,et al.  Activation of D1 dopamine receptors increases surface expression of AMPA receptors and facilitates their synaptic incorporation in cultured hippocampal neurons , 2006, Journal of neurochemistry.

[12]  Vivien Chevaleyre,et al.  Endocannabinoid-mediated synaptic plasticity in the CNS. , 2006, Annual review of neuroscience.

[13]  J. Weiss,et al.  Calcium-permeable AMPA channels in neurodegenerative disease and ischemia , 2006, Current Opinion in Neurobiology.

[14]  R. Malenka,et al.  Synaptic scaling mediated by glial TNF-α , 2006, Nature.

[15]  J. Rossier,et al.  Constitutive Activation Drives Compartment-Selective Endocytosis and Axonal Targeting of Type 1 Cannabinoid Receptors , 2006, The Journal of Neuroscience.

[16]  K. Jin,et al.  Molecular Mechanisms of Cannabinoid Protection from Neuronal Excitotoxicity , 2006, Molecular Pharmacology.

[17]  J. Gensel,et al.  Behavioral and histological characterization of unilateral cervical spinal cord contusion injury in rats. , 2006, Journal of neurotrauma.

[18]  T. Soderling,et al.  Extrasynaptic Membrane Trafficking Regulated by GluR1 Serine 845 Phosphorylation Primes AMPA Receptors for Long-term Potentiation* , 2006, Journal of Biological Chemistry.

[19]  M. Pickering,et al.  Actions of TNF‐α on glutamatergic synaptic transmission in the central nervous system , 2005 .

[20]  M. Wolf,et al.  Dopamine Receptor Stimulation Modulates AMPA Receptor Synaptic Insertion in Prefrontal Cortex Neurons , 2005, The Journal of Neuroscience.

[21]  F. Poulsen,et al.  Modulator Effects of Interleukin-1β and Tumor Necrosis Factor-α on AMPA-Induced Excitotoxicity in Mouse Organotypic Hippocampal Slice Cultures , 2005, The Journal of Neuroscience.

[22]  J. Weiss,et al.  Tumor necrosis-factor-alpha (TNF-α) induces rapid insertion of Ca2+-permeable α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA)/kainate (Ca-A/K) channels in a subset of hippocampal pyramidal neurons , 2005, Experimental Neurology.

[23]  R. Malenka,et al.  Differential Regulation of AMPA Receptor and GABA Receptor Trafficking by Tumor Necrosis Factor-α , 2005, The Journal of Neuroscience.

[24]  F. Crews,et al.  TNFα potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NFκB inhibition , 2005, Brain Research.

[25]  F. Sharp,et al.  The impact of excitotoxic blockade on the evolution of injury following combined mechanical and hypoxic insults in primary rat neuronal culture , 2004, Neurobiology of Disease.

[26]  L. Petrocellis,et al.  The endocannabinoid system and its therapeutic exploitation , 2004, Nature Reviews Drug Discovery.

[27]  M. Beattie,et al.  TNFalpha-induced AMPA-receptor trafficking in CNS neurons; relevance to excitotoxicity? , 2004, Neuron glia biology.

[28]  E. Tzavara,et al.  Cannabinoids reduce cAMP levels in the striatum of freely moving rats: an in vivo microdialysis study , 2004, Brain Research.

[29]  M. Eder,et al.  CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity , 2003, Science.

[30]  V. Manganiello,et al.  Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. , 2002, Diabetes.

[31]  E. Cottone,et al.  CB1 cannabinoid receptors in amphibian spinal cord: relationships with some nociception markers , 2002, Journal of Chemical Neuroanatomy.

[32]  S. Brull,et al.  Acute topical application of tumor necrosis factor alpha evokes protein kinase A-dependent responses in rat sensory neurons. , 2002, Journal of neurophysiology.

[33]  A. Howlett.  The cannabinoid receptors. , 2002, Prostaglandins & other lipid mediators.

[34]  Rena Li,et al.  Target Depletion of Distinct Tumor Necrosis Factor Receptor Subtypes Reveals Hippocampal Neuron Death and Survival through Different Signal Transduction Pathways , 2002, The Journal of Neuroscience.

[35]  S. Mohand-Said,et al.  Neurodegenerative and Neuroprotective Effects of Tumor Necrosis Factor (TNF) in Retinal Ischemia: Opposite Roles of TNF Receptor 1 and TNF Receptor 2 , 2002, The Journal of Neuroscience.

[36]  Wade Morishita,et al.  Control of Synaptic Strength by Glial TNFα , 2002, Science.

[37]  R. Go,et al.  The role of TNF and its receptors in Alzheimer’s disease , 2001, Neurobiology of Aging.

[38]  Roger A. Nicoll,et al.  Metabotropic glutamate receptor activation causes a rapid redistribution of AMPA receptors , 2001, Neuropharmacology.

[39]  Mark F. Bear,et al.  Internalization of ionotropic glutamate receptors in response to mGluR activation , 2001, Nature Neuroscience.

[40]  S. McAllister,et al.  Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity , 2001, Neuroscience Letters.

[41]  M. Beattie,et al.  Tumor Necrosis Factor-α Induces cFOS and Strongly Potentiates Glutamate-Mediated Cell Death in the Rat Spinal Cord , 2001, Neurobiology of Disease.

[42]  P. Weigel,et al.  Mechanisms of cell death in primary cortical neurons and PC12 cells , 2001, Journal of neuroscience research.

[43]  I. Galve-Roperh,et al.  The CB(1) cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan. , 2001, Molecular pharmacology.

[44]  Douglas K. Anderson,et al.  TNF‐α stimulates caspase‐3 activation and apoptotic cell death in primary septo‐hippocampal cultures , 2001, Journal of neuroscience research.

[45]  J. Szelényi.  Cytokines and the central nervous system , 2001, Brain Research Bulletin.

[46]  M. Bennett,et al.  Status epilepticus decreases glutamate receptor 2 mRNA and protein expression in hippocampal pyramidal cells before neuronal death. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[47]  B. Sakmann,et al.  Coincidence detection and changes of synaptic efficacy in spiny stellate neurons in rat barrel cortex , 1999, Nature Neuroscience.

[48]  L. Steinman,et al.  The role of TNFα and lymphotoxin in demyelinating disease , 1999 .

[49]  M. Bennett,et al.  Knockdown of AMPA Receptor GluR2 Expression Causes Delayed Neurodegeneration and Increases Damage by Sublethal Ischemia in Hippocampal CA1 and CA3 Neurons , 1999, The Journal of Neuroscience.

[50]  J. Wrathall,et al.  Alterations in AMPA Receptor Subunit Expression after Experimental Spinal Cord Contusion Injury , 1999, The Journal of Neuroscience.

[51]  J. Hallenbeck,et al.  Dual role of tumor necrosis factor alpha in brain injury. , 1999, Cytokine & growth factor reviews.

[52]  M. Shen,et al.  Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. , 1998, Molecular pharmacology.

[53]  L. Epstein,et al.  HIV-1 Tat Induces Neuronal Death via Tumor Necrosis Factor-α and Activation of Non-N-methyl-d-aspartate Receptors by a NFκB-Independent Mechanism* , 1998, The Journal of Biological Chemistry.

[54]  T. Babb,et al.  Increased densities of AMPA GluR1 subunit proteins and presynaptic mossy fiber sprouting in the fascia dentata of human hippocampal epilepsy , 1998, Brain Research.

[55]  E. Vizi,et al.  AMRINONE AND THEOPHYLLINE DIFFERENTIALLY REGULATE CYTOKINE AND NITRIC OXIDE PRODUCTION IN ENDOTOXEMIC MICE , 1997, Shock.

[56]  J. Weiss,et al.  Motor Neurons Are Selectively Vulnerable to AMPA/Kainate Receptor-Mediated Injury In Vitro , 1996, The Journal of Neuroscience.

[57]  B. Sakmann,et al.  Calcium-permeable AMPA-kainate receptors in fusiform cerebellar glial cells. , 1992, Science.

[58]  S. Heinemann,et al.  Ca2+ permeability of KA-AMPA--gated glutamate receptor channels depends on subunit composition , 1991, Science.

[59]  R. Malenka,et al.  Synaptic scaling mediated by glial TNF-alpha. , 2006, Nature.

[60]  M. Pickering,et al.  Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. , 2005, Experimental physiology.

[61]  J. Weiss,et al.  Tumor necrosis-factor-alpha (TNF-alpha) induces rapid insertion of Ca2+-permeable alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA)/kainate (Ca-A/K) channels in a subset of hippocampal pyramidal neurons. , 2005, Experimental neurology.

[62]  F. Crews,et al.  TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition. , 2005, Brain research.

[63]  R. Malenka,et al.  AMPA receptor trafficking and synaptic plasticity. , 2002, Annual review of neuroscience.

[64]  R. Malenka,et al.  Control of synaptic strength by glial TNFalpha. , 2002, Science.

[65]  M. Beattie,et al.  Tumor necrosis factor-alpha induces cFOS and strongly potentiates glutamate-mediated cell death in the rat spinal cord. , 2001, Neurobiology of disease.

[66]  H. Ichinose,et al.  Cytokines in Parkinson’s Disease , 2000 .

[67]  L. Steinman,et al.  The role of TNFalpha and lymphotoxin in demyelinating disease. , 1999, Annals of the rheumatic diseases.

[68]  D. Feldmeyer,et al.  Neurological dysfunctions in mice expressing different levels of the Q/R site–unedited AMPAR subunit GluR–B , 1999, Nature Neuroscience.

[69]  M. Shen,et al.  Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture. , 1999, Molecular pharmacology.

[70]  Shuxian Hu,et al.  Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. , 1994, Developmental neuroscience.

[71]  M. Patel,et al.  N-methyl-D-aspartate receptors mediate cyanide-induced cytotoxicity in hippocampal cultures. , 1993, Neurotoxicology.

[72]  D. Diloreto,et al.  Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. , 1993, Developmental neuroscience.